Review decisions

Showing 10 results of 287 total
Summary Safety Review - Olanzapine - Assessing the Potential Risks of Syndrome of Inappropriate Secretion of Antidiuretic Hormone and Hyponatremia
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1725462803755
DIN(s): 02229250, 02229269, 02229277, 02229285, 02238850, 02238851, 02243086, 02243087, 02243088, 02243089, 02247099, 02276712, 02276720, 02276739, 02276747, 02276755, 02281791, 02281805, 02281813, 02281821, 02281848, 02303116, 02303159, 02303167, 02303175, 02303183, 02303191, 02303205, 02303213, 02310341, 02310368, 02310376, 02310384, 02310392, 02311968, 02311976, 02311984, 02311992, 02312018, 02327775, 02327783, 02327791, 02327805, 02333015, 02337126, 02337134, 02337142, 02337150, 02337169, 02338645, 02338653, 02338661, 02343665, 02343673, 02343681, 02343703, 02352974, 02352982, 02352990, 02359707, 02360616, 02360624, 02360632, 02360640, 02372819, 02372827, 02372835, 02372843, 02372851, 02385864, 02385872, 02385880, 02385899, 02385902, 02385910, 02406624, 02406632, 02406640, 02406659, 02410141, 02410168, 02410176, 02410184, 02410192, 02417243, 02417251, 02417278, 02417286, 02417294, 02417308, 02421704, 02425114, 02436965, 02436973, 02436981, 02448726, 02448734, 02448742, 02448750, 02487608, 02487616, 02487632, 02536188, 02536196, 02536218, 02536226, 02545586, 02545594, 02545608, 02545616, 02545624, 02545632
Issued / Original Publication Date: 2024-09-06
Updated Date: 2024-09-06
Summary Safety Review - Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors (canagliflozin, dapagliflozin, empagliflozin) - Assessing the Potential Risks of Prolonged or Incident Diabetic Ketoacidosis Despite Stopping Treatment in Adult Patients with Type 2 Diabetes
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1724175682293
DIN(s): 02425483, 02425491, 02435462, 02435470, 02443937, 02443945, 02449935, 02449943, 02455404, 02455420, 02455439, 02455455, 02456575, 02456583, 02456591, 02456605, 02456613, 02456621, 02518732, 02518740, 02519852, 02519860, 02520591, 02520605, 02523590, 02523604, 02527189, 02527197, 02528975, 02528983, 02531364, 02531372, 02531402, 02531410, 02531550, 02531569, 02533049, 02533057, 02533073, 02533081, 02535297, 02535300, 02535866, 02535874, 02536153, 02536161, 02537656, 02537664, 02538334, 02538342, 02543184, 02543192
Issued / Original Publication Date: 2024-08-21
Updated Date: 2024-08-21
Summary Safety Review - Breast Implants - Assessing the Potential Risk of Breast Implant Illness Representative Symptoms and Diseases
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1722261038121
Issued / Original Publication Date: 2024-08-09
Updated Date: 2024-08-09
Summary Safety Review - Isotretinoin - Assessing the Potential Risk of Sexual Dysfunction, Including Persistent Sexual Dysfunction After Drug Discontinuation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1717527382406
DIN(s): 00582344, 00582352, 02257955, 02257963, 02309173, 02396971, 02396998, 02397005, 02397013, 02539047, 02539055, 02539063, 02539071
Issued / Original Publication Date: 2024-06-07
Updated Date: 2024-06-07
Summary Safety Review - Nexavar (sorafenib) - Assessing the Potential Risk of Tumour Lysis Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1715006032208
DIN(s): 02284227
Issued / Original Publication Date: 2024-05-16
Updated Date: 2024-05-16
Summary Safety Review - Iodinated Contrast Medium - Assessing the Potential Risk of Hypothyroidism in Children Under 3 Years of Age
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1714657204971
DIN(s): 00386685, 00397466, 01900854, 02035626, 02078600, 02078619, 02145766, 02145774, 02172739, 02172747, 02172755, 02228564, 02229013, 02229021, 02229048, 02242121, 02242122, 02387441
Issued / Original Publication Date: 2024-05-10
Updated Date: 2024-05-10
Summary Safety Review - Neulasta (pegfilgrastim) - Assessing the Potential Risks of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1712840271387
DIN(s): 02249790, 02474565, 02484153, 02497395, 02506238, 02529343
Issued / Original Publication Date: 2024-04-19
Updated Date: 2024-04-19
Summary Safety Review - Ibrance (palbociclib) - Assessing the Potential Risk of Venous Thromboembolism
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1707157428464
DIN(s): 02453150, 02453169, 02453177, 02493535, 02493543, 02493551
Issued / Original Publication Date: 2024-02-09
Updated Date: 2024-02-09
Summary Safety Review - Amiodarone - Assessing the Potential Risk of Primary Graft Dysfunction Following Heart Transplantation
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1706035839788
DIN(s): 02239835, 02242325, 02242472, 02243836, 02245248, 02246194, 02246331, 02247217, 02249502, 02292173, 02294508, 02309661, 02364336, 02385465, 02423227, 02427346, 02531844
Issued / Original Publication Date: 2024-02-01
Updated Date: 2024-02-01
Summary Safety Review - Colistin (colistimethate sodium) - Assessing the Potential Risk of Pseudo-Bartter Syndrome
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR1705515920269
DIN(s): 00476420, 02244849, 02403544
Issued / Original Publication Date: 2024-01-18
Updated Date: 2024-01-18

Displaying 1 - 10 of 287 | Page 1 of 29
Report a problem or mistake on this page
Please select all that apply:
Date modified: